LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca2+-FAK signal pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca2+-FAK signal pathway
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 11, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-08
DOI
10.1038/s41419-020-2633-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling
- (2019) Jialei Hu et al. INTERNATIONAL JOURNAL OF CANCER
- New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis
- (2019) Yutong Sun et al. Cancers
- Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling
- (2019) Min-Hui Yang et al. Molecular Cancer
- Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer
- (2019) Shouping Xu et al. Molecular Cancer
- NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer
- (2019) Hongfei Yan et al. Cancer Management and Research
- HOX transcript antisense RNA (HOTAIR) in cancer
- (2019) Xiaohan Qu et al. CANCER LETTERS
- 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer
- (2019) Jing Peng et al. CELL CYCLE
- The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer
- (2019) Clément Lecerf et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The m6A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca2+ influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway
- (2019) Dongkui Gong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mitochondrial fission promotes cell migration by Ca2+ /CaMKII/ERK/FAK pathway in hepatocellular carcinoma
- (2018) Xiacheng Sun et al. LIVER INTERNATIONAL
- LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis
- (2018) Yanyan Tang et al. Molecular Cancer
- Long non-coding RNA FOXC2-AS1 predicts poor survival in breast cancer patients and promotes cell proliferation
- (2018) Haisong Yang et al. ONCOLOGY RESEARCH
- Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer
- (2018) Jie Shen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment
- (2018) Changhao Chen et al. Nature Communications
- A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability
- (2018) Mahdieh Jadaliha et al. PLoS Genetics
- Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2
- (2018) Yanbo Chen et al. GENE
- LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation
- (2017) Yan-wen Liu et al. Molecular Cancer
- Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells
- (2017) Xin Zhang et al. Molecular Cancer
- Long non-coding RNAs: a rising biotarget in colorectal cancer
- (2017) Jian Luo et al. Oncotarget
- Targeting calcium signaling in cancer therapy
- (2017) Chaochu Cui et al. Acta Pharmaceutica Sinica B
- Focal Adhesion–Independent Cell Migration
- (2016) Ewa K. Paluch et al. Annual Review of Cell and Developmental Biology
- Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies
- (2016) Daniel A. Goldstein et al. Clinical Colorectal Cancer
- Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells
- (2016) Jorge Eduardo Shortrede et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The histidine-rich calcium binding protein (HRC) promotes tumor metastasis in hepatocellular carcinoma and is upregulated by SATB1
- (2015) Jingmei Liu et al. Oncotarget
- S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer
- (2015) Ya-Ling Hsu et al. Oncotarget
- FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways
- (2014) Yan-Mei Cui et al. CANCER LETTERS
- Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways
- (2014) Zhi Dai et al. JOURNAL OF PATHOLOGY
- FOXC2 promotes colorectal cancer metastasis by directly targeting MET
- (2014) Y-M Cui et al. ONCOGENE
- Targeting long non-coding RNA to therapeutically upregulate gene expression
- (2013) Claes Wahlestedt NATURE REVIEWS DRUG DISCOVERY
- Gene regulation by antisense transcription
- (2013) Vicent Pelechano et al. NATURE REVIEWS GENETICS
- Ganoderiol A-Enriched Extract Suppresses Migration and Adhesion of MDA-MB-231 Cells by Inhibiting FAK-SRC-Paxillin Cascade Pathway
- (2013) Guo-Sheng Wu et al. PLoS One
- Calcium-permeable ion channels in control of autophagy and cancer
- (2013) Artem Kondratskyi Frontiers in Physiology
- Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat
- (2012) Claudia Carrieri et al. NATURE
- Nanoscale architecture of integrin-based cell adhesions
- (2010) Pakorn Kanchanawong et al. NATURE
- Paxillin comes of age
- (2008) N. O. Deakin et al. JOURNAL OF CELL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started